Literature DB >> 8383170

Ribonucleotide reductase-deficient mutants of pseudorabies virus are avirulent for pigs and induce partial protective immunity.

N de Wind1, A Berns, A Gielkens, T Kimman.   

Abstract

We have mutagenized and mapped the gene encoding the large subunit of ribonucleotide reductase (RR1) in pseudorabies virus (PRV; synonyms Aujeszky's disease virus, suid herpesvirus type 1). PRV strains carrying an oligonucleotide that leads to termination of translation of the RR1 gene are avirulent for mice. We subsequently constructed a PRV strain carrying a deletion in the RR1 gene and also a PRV strain carrying both the deletion in the RR1 gene and a deletion in the glycoprotein g1 gene, which is a marker for PRV virulence. Both PRV strains were assayed for virulence and immunogenicity in pigs, the natural host for PRV. In contrast to a marker-rescued PRV strain, these RR1-deleted mutants were avirulent, were shed in very low titres in the oropharyngeal fluid by the animals, and induced low titres of neutralizing antibodies. However, protection against clinical signs after infection with virulent PRV was induced by both RR1-deleted mutants. The relative importance of viral RR and thymidine kinase enzymes for deoxynucleotide synthesis in viral replication is discussed. In addition, we discuss the potential use of RR as a target for anti-herpesviral drugs and the use of PRV strains, deleted for the RR1 gene, as vaccine strains.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8383170     DOI: 10.1099/0022-1317-74-3-351

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  16 in total

1.  Expression of an altered ribonucleotide reductase activity associated with the replication of murine cytomegalovirus in quiescent fibroblasts.

Authors:  D Lembo; G Gribaudo; A Hofer; L Riera; M Cornaglia; A Mondo; A Angeretti; M Gariglio; L Thelander; S Landolfo
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

Review 2.  Molecular biology of pseudorabies virus: impact on neurovirology and veterinary medicine.

Authors:  Lisa E Pomeranz; Ashley E Reynolds; Christoph J Hengartner
Journal:  Microbiol Mol Biol Rev       Date:  2005-09       Impact factor: 11.056

3.  Glycoprotein D-negative pseudorabies virus can spread transneuronally via direct neuron-to-neuron transmission in its natural host, the pig, but not after additional inactivation of gE or gI.

Authors:  W Mulder; J Pol; T Kimman; G Kok; J Priem; B Peeters
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

4.  Vaccinia virus-encoded ribonucleotide reductase subunits are differentially required for replication and pathogenesis.

Authors:  Don B Gammon; Branawan Gowrishankar; Sophie Duraffour; Graciela Andrei; Chris Upton; David H Evans
Journal:  PLoS Pathog       Date:  2010-07-08       Impact factor: 6.823

5.  Pseudorabies virus US3 protein kinase mediates actin stress fiber breakdown.

Authors:  Geert Van Minnebruggen; Herman W Favoreel; Liesbeth Jacobs; Hans J Nauwynck
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

6.  Deletion of the varicella-zoster virus large subunit of ribonucleotide reductase impairs growth of virus in vitro.

Authors:  T C Heineman; J I Cohen
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

7.  Identification and characterization of pseudorabies virus dUTPase.

Authors:  A Jöns; T C Mettenleiter
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

8.  A deletion at the UL/IR junction reduces pseudorabies virus neurovirulence.

Authors:  H J Dean; A K Cheung
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

9.  Characterization of the novel protein kinase activity present in the R1 subunit of herpes simplex virus ribonucleotide reductase.

Authors:  J Cooper; J Conner; J B Clements
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

10.  Whole-genome analysis of pseudorabies virus gene expression by real-time quantitative RT-PCR assay.

Authors:  Dóra Tombácz; Judit S Tóth; Pál Petrovszki; Zsolt Boldogkoi
Journal:  BMC Genomics       Date:  2009-10-23       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.